UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Necrosis Factor Induces the Production of Urokinase-Type Plasminogen Activator by Human Endothelial Cells

Blood, 1990-05, Vol.75 (10), p.1991-1998

1990

Volltextzugriff (PDF)

Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass

Thrombosis and haemostasis, 1995-05, Vol.73 (5), p.825-828

1995

Volltextzugriff (PDF)

Role of the Contact System in Fibrinolysis

Seminars in thrombosis and hemostasis, 1987-01, Vol.13 (1), p.50-68

1987

Volltextzugriff (PDF)

Plasminogen activators in synovial fluid and plasma from patients with arthritis

Annals of the rheumatic diseases, 1992-08, Vol.51 (8), p.965-968

1992

Volltextzugriff (PDF)

Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study

Blood coagulation & fibrinolysis, 2001-09, Vol.12 (6), p.453-458

2001

Volltextzugriff (PDF)

Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator

Clinical pharmacology and therapeutics, 1996-11, Vol.60 (5), p.504-511

1996

Volltextzugriff (PDF)

Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation

Thrombosis and haemostasis, 1992-08, Vol.68 (2), p.180-184

1992

Volltextzugriff (PDF)

Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma

Thrombosis and haemostasis, 1991, Vol.65 (1), p.82-86

1991

Volltextzugriff (PDF)

Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weight

Thrombosis and haemostasis, 1995-12, Vol.74 (6), p.1491-1496

1995

Volltextzugriff (PDF)

Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects

Diabetes care, 1992-08, Vol.15 (8), p.991-996

1992

Volltextzugriff (PDF)

Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection

Thrombosis and haemostasis, 1992-07, Vol.68 (1), p.19-23

1992

Volltextzugriff (PDF)

Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters

Thrombosis and haemostasis, 1994-02, Vol.71 (2), p.236

1994

Volltextzugriff (PDF)

Quantitation of urokinase antigen in plasma and culture media by use of an elisa

Thrombosis research, 1986-09, Vol.43 (5), p.569-577

1986

Volltextzugriff (PDF)

DDAVP induces systemic release of urokinase-type plasminogen activator

Thrombosis and haemostasis, 1989-09, Vol.62 (2), p.686-689

1989

Volltextzugriff (PDF)

An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels

Thrombosis and haemostasis, 1995-12, Vol.74 (6), p.1497-1500

1995

Volltextzugriff (PDF)

An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein

Thrombosis and haemostasis, 1991-02, Vol.65 (2), p.144-148

1991

Volltextzugriff (PDF)

Pharmacokinetics of saruplase, a recombinant unglycosylated human single-chain urokinase-type plasminogen activator and its effects on fibrinolytic and haemostatic parameters in healthy male subjects

Thrombosis and haemostasis, 1993, Vol.70 (2), p.320-325

1993

Volltextzugriff (PDF)

Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release

Thrombosis and haemostasis, 1991-10, Vol.66 (4), p.426-429

1991

Volltextzugriff (PDF)

Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man

Thrombosis and haemostasis, 1988-06, Vol.59 (3), p.404-411

1988

Volltextzugriff (PDF)

The Rationale of Prevention of Thrombosis by Enhancing Blood Levels of Single-Chain Urokinase-type Plasminogen Activator (scuPA)

Annals of the New York Academy of Sciences, 1992-12, Vol.667 (1), p.278-280

1992

Volltextzugriff (PDF)

Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease

Thrombosis and haemostasis, 1992-08, Vol.68 (2), p.102-105

1992

Volltextzugriff (PDF)

Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood

Annals of hematology, 1994, Vol.68 (1), p.43-48

1994

Volltextzugriff (PDF)

Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT)

Thrombosis and haemostasis, 1993-01, Vol.69 (1), p.56-59

1993

Volltextzugriff (PDF)

Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotinin

Thrombosis and haemostasis, 1994-01, Vol.71 (1), p.12-14

1994

Volltextzugriff (PDF)

The post-thrombolytic era: is it possible to prevent thrombosis by stimulating indigenous fibrinolysis?

Fibrinolysis, 1993, Vol.7, p.42-43

Dooijewaard, G.

1993

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(91)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor Necrosis Factor Induces the Production of Urokinase-Type Plasminogen Activator by Human Endothelial Cells

Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass

Role of the Contact System in Fibrinolysis

Plasminogen activators in synovial fluid and plasma from patients with arthritis

Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study

Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator

Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation

Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma

Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weight

Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects

Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection

Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters

Quantitation of urokinase antigen in plasma and culture media by use of an elisa

DDAVP induces systemic release of urokinase-type plasminogen activator

An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels

An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein

Pharmacokinetics of saruplase, a recombinant unglycosylated human single-chain urokinase-type plasminogen activator and its effects on fibrinolytic and haemostatic parameters in healthy male subjects

Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release

Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man

The Rationale of Prevention of Thrombosis by Enhancing Blood Levels of Single-Chain Urokinase-type Plasminogen Activator (scuPA)

Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease

Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood

Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT)

Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotinin

The post-thrombolytic era: is it possible to prevent thrombosis by stimulating indigenous fibrinolysis?

Suchergebnisse filtern